Novartis to run COVID-19 trial of antimalaria drug touted by Trump
April 20, 2020 at 05:49 AM EDT
The antimalaria drug that President Donald Trump has repeatedly touted will be put to the test.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|